ROI

An obscure independent is polling at 7% in Florida's gubernatorial race. It’s a market signal that voter frustration with economic pain is reaching a tipping point.

The hiring of Patrick Foley isn't just a new job—it's a sign of a larger war for talent as private equity pours billions into the high-stakes national security sector.

A new strategic alliance between a pharma giant and a leading non-profit is deploying a $20M plan to close the deadly prostate cancer survival gap.

A 23% national drop in overdose deaths signals progress, but regional disparities and a volatile drug supply show the fight is far from over.

A new partnership between Klick Labs and Mayo Clinic aims to detect disease using your voice. But what does this mean for the future of our health systems?

For decades, patients with advanced chondrosarcoma had no options. Now, a new drug's journey to the FDA offers a lifeline and a lesson in medical neglect.

Ottawa is injecting hundreds of millions into sports, from local events to the World Cup. But this isn't just about medals; it's a critical bid to repair a fractured system.

EKA Solutions has launched Omni-TMS™, an AI-native platform that's more than an upgrade—it's a strategic bid to become the core OS for logistics.

A landmark partnership between US and Indian firms aims to build a massive 1 GW AI data campus in Florida, signaling a strategic shift toward vertically integrated power and compute.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

A new report reveals a record 242 US cities have starter homes costing $1M, tripling since 2020. This isn't just a number—it's a fundamental market reset.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

A missed clinical trial endpoint is often the end. For Elicio Therapeutics, a deeper data dive reveals a potential path forward for a high-need patient group.

Dominari Securities' successful $200M fund for the SpaceX IPO isn't just a trade; it's a masterclass in the new mechanics of power and profit on Wall Street.

LONGi celebrates a massive solar milestone, but with industry margins squeezed, we analyze if its high-efficiency bet can deliver long-term value.

As JetZero breaks ground on a factory set to create 14,500 jobs, its partnership with Deloitte aims to solve a critical problem: who will fill them?

Stunning new US/EU data for BTK inhibitor orelabrutinib signals a major push into Western markets, challenging established blood cancer therapies.

Top federal ministers, Canada's new CPHO, and the Fentanyl Czar will unveil updated opioid data and actions. Will it be enough to turn the tide on a crisis?

Cadeler's new Wind Peak vessel completes its first major project, installing 100 turbines at the massive Sofia Wind Farm, a critical step for UK energy security.

The nation's top luxury builder is launching a new community in affluent Somerset County. But what does it say about the future of suburban development?